NovoCure Ltd - ORD SHS (NVCR)

Historical Portfolio Holders from Q4 2015 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / ORD SHS
Shares, excl. options Q2 2024
92.9M
Holdings value Q2 2024
$1.59B
Value change Q2 2024
+$79.8M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
227
Number of buys Q2 2024
116
Number of sells Q2 2024
-112
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 92.9M $1.59B +$79.8M $17.13 228
2024 Q1 89.1M $1.39B -$18.3M $15.63 230
2023 Q4 90.5M $1.35B -$15.7M $14.93 214
2023 Q3 91.2M $1.47B -$63.1M $16.15 221
2023 Q2 89.2M $3.7B -$15.6M $41.50 254
2023 Q1 89.3M $5.37B +$286M $60.14 286
2022 Q4 83.9M $6.15B -$21.2M $73.35 289
2022 Q3 83M $6.31B +$218M $75.98 286
2022 Q2 80M $5.56B -$39.2M $69.50 291
2022 Q1 81.2M $6.72B +$212M $82.85 290
2021 Q4 79M $5.93B +$46.2M $75.08 291
2021 Q3 77.5M $9B -$78.5M $116.17 297
2021 Q2 77.6M $17.2B +$681M $221.82 350
2021 Q1 73M $9.65B +$117M $132.18 312
2020 Q4 74.2M $12.8B +$239M $173.04 347
2020 Q3 73M $8.13B +$543M $111.31 267
2020 Q2 69.1M $4.1B -$79.3M $59.30 255
2020 Q1 70.3M $4.73B +$76M $67.34 260
2019 Q4 69M $5.81B +$161M $84.27 251
2019 Q3 66.7M $4.99B +$92.4M $74.78 232
2019 Q2 65.8M $4.16B +$195M $63.23 187
2019 Q1 63.5M $3.06B +$298M $48.17 192
2018 Q4 57.3M $1.92B +$53.7M $33.48 162
2018 Q3 54.7M $2.87B +$204M $52.40 172
2018 Q2 51.8M $1.62B +$259M $31.30 158
2018 Q1 44M $959M +$148M $21.80 132
2017 Q4 37.4M $756M +$13.1M $20.20 123
2017 Q3 36.8M $731M +$98.7M $19.85 101
2017 Q2 31.9M $551M +$204M $17.30 82
2017 Q1 20.2M $164M +$27M $8.10 69
2016 Q4 20.1M $158M +$10.1M $7.85 75
2016 Q3 18.8M $161M -$21.8M $8.54 62
2016 Q2 19.4M $227M +$67.5M $11.67 65
2016 Q1 13.6M $197M +$32.4M $14.48 56
2015 Q4 11.3M $249M +$249M $22.36 47